Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Identifieur interne : 000513 ( Main/Exploration ); précédent : 000512; suivant : 000514

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Auteurs : Achille Aouba [Oman] ; Aurelie Baldolli [France] ; Loïk Geffray [France] ; Renaud Verdon [France] ; Emmanuel Bergot [France] ; Nicolas Martin-Silva [France] ; Aurélien Justet [France]

Source :

RBID : pubmed:32376597

Descripteurs français

English descriptors


DOI: 10.1136/annrheumdis-2020-217706
PubMed: 32376597


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</title>
<author>
<name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<wicri:noRegion>Caen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Lisieux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32376597</idno>
<idno type="pmid">32376597</idno>
<idno type="doi">10.1136/annrheumdis-2020-217706</idno>
<idno type="wicri:Area/Main/Corpus">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001420</idno>
<idno type="wicri:Area/Main/Curation">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001420</idno>
<idno type="wicri:Area/Main/Exploration">001420</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</title>
<author>
<name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<wicri:noRegion>Caen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Lisieux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName>
<region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged, 80 and over (MeSH)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Azithromycin (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>C-Reactive Protein (immunology)</term>
<term>Coronavirus Infections (diagnostic imaging)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Disease Progression (MeSH)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Interleukin 1 Receptor Antagonist Protein (therapeutic use)</term>
<term>Lung (diagnostic imaging)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnostic imaging)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Respiratory Distress Syndrome, Adult (physiopathology)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen (MeSH)</term>
<term>Antagoniste du récepteur à l'interleukine-1 (usage thérapeutique)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antienzymes (usage thérapeutique)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à coronavirus (imagerie diagnostique)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (imagerie diagnostique)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (physiopathologie)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Protéine C-réactive (immunologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Syndrome de détresse respiratoire de l'adulte (physiopathologie)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Évolution de la maladie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>C-Reactive Protein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Azithromycin</term>
<term>Enzyme Inhibitors</term>
<term>Hydroxychloroquine</term>
<term>Interleukin 1 Receptor Antagonist Protein</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Lung</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Protéine C-réactive</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antagoniste du récepteur à l'interleukine-1</term>
<term>Antibactériens</term>
<term>Antienzymes</term>
<term>Azithromycine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged, 80 and over</term>
<term>Betacoronavirus</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Severity of Illness Index</term>
<term>Tomography, X-Ray Computed</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tomodensitométrie</term>
<term>Unités de soins intensifs</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32376597</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>79</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</ArticleTitle>
<Pagination>
<MedlinePgn>1381-1382</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217706</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aouba</LastName>
<ForeName>Achille</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0003-1726-3811</Identifier>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baldolli</LastName>
<ForeName>Aurelie</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Geffray</LastName>
<ForeName>Loïk</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verdon</LastName>
<ForeName>Renaud</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bergot</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Pulmonology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin-Silva</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Justet</LastName>
<ForeName>Aurélien</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pulmonology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>05</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053590">Interleukin 1 Receptor Antagonist Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053590" MajorTopicYN="N">Interleukin 1 Receptor Antagonist Protein</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">antirheumatic agents</Keyword>
<Keyword MajorTopicYN="Y">biological therapy</Keyword>
<Keyword MajorTopicYN="Y">cytokines</Keyword>
<Keyword MajorTopicYN="Y">interleukin 1 receptor antagonist protein</Keyword>
<Keyword MajorTopicYN="Y">therapeutics</Keyword>
</KeywordList>
<CoiStatement>Competing interests: AA, outside of this work, obtained non-financial support for research in giant cells arteritis with Anakinra from SOBI Phramaceutics, .</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32376597</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-217706</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-217706</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Oman</li>
</country>
<region>
<li>Basse-Normandie</li>
<li>Région Normandie</li>
</region>
<settlement>
<li>Caen</li>
<li>Lisieux</li>
</settlement>
</list>
<tree>
<country name="Oman">
<noRegion>
<name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
</noRegion>
</country>
<country name="France">
<region name="Région Normandie">
<name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
</region>
<name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000513 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000513 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32376597
   |texte=   Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32376597" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021